Your browser doesn't support javascript.
A SARS-CoV-2 Cluster in an Acute Care Hospital.
Klompas, Michael; Baker, Meghan A; Rhee, Chanu; Tucker, Robert; Fiumara, Karen; Griesbach, Diane; Bennett-Rizzo, Carin; Salmasian, Hojjat; Wang, Rui; Wheeler, Noah; Gallagher, Glen R; Lang, Andrew S; Fink, Timelia; Baez, Stephanie; Smole, Sandra; Madoff, Larry; Goralnick, Eric; Resnick, Andrew; Pearson, Madelyn; Britton, Kathryn; Sinclair, Julia; Morris, Charles A.
  • Klompas M; Harvard Medical School, Harvard Pilgrim Health Care Institute, and Brigham and Women's Hospital, Boston, Massachusetts (M.K., M.A.B., C.R.).
  • Baker MA; Harvard Medical School, Harvard Pilgrim Health Care Institute, and Brigham and Women's Hospital, Boston, Massachusetts (M.K., M.A.B., C.R.).
  • Rhee C; Harvard Medical School, Harvard Pilgrim Health Care Institute, and Brigham and Women's Hospital, Boston, Massachusetts (M.K., M.A.B., C.R.).
  • Tucker R; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Fiumara K; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Griesbach D; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Bennett-Rizzo C; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Salmasian H; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Wang R; Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts (R.W.).
  • Wheeler N; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Gallagher GR; Massachusetts Department of Public Health, Boston, Massachusetts (G.R.G., A.S.L., T.F., S.B., S.S., L.M.).
  • Lang AS; Massachusetts Department of Public Health, Boston, Massachusetts (G.R.G., A.S.L., T.F., S.B., S.S., L.M.).
  • Fink T; Massachusetts Department of Public Health, Boston, Massachusetts (G.R.G., A.S.L., T.F., S.B., S.S., L.M.).
  • Baez S; Massachusetts Department of Public Health, Boston, Massachusetts (G.R.G., A.S.L., T.F., S.B., S.S., L.M.).
  • Smole S; Massachusetts Department of Public Health, Boston, Massachusetts (G.R.G., A.S.L., T.F., S.B., S.S., L.M.).
  • Madoff L; Massachusetts Department of Public Health, Boston, Massachusetts (G.R.G., A.S.L., T.F., S.B., S.S., L.M.).
  • Goralnick E; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Resnick A; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Pearson M; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Britton K; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Sinclair J; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
  • Morris CA; Brigham and Women's Hospital, Boston, Massachusetts (R.T., K.F., D.G., C.B., H.S., N.W., E.G., A.R., M.P., K.B., J.S., C.A.M.).
Ann Intern Med ; 174(6): 794-802, 2021 06.
Article in English | MEDLINE | ID: covidwho-1069941
ABSTRACT

BACKGROUND:

Little is known about clusters of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in acute care hospitals.

OBJECTIVE:

To describe the detection, mitigation, and analysis of a large cluster of SARS-CoV-2 infections in an acute care hospital with mature infection control policies.

DESIGN:

Descriptive study.

SETTING:

Brigham and Women's Hospital, Boston, Massachusetts.

PARTICIPANTS:

Patients and staff with cluster-related SARS-CoV-2 infections. INTERVENTION Close contacts of infected patients and staff were identified and tested every 3 days, patients on affected units were preemptively isolated and repeatedly tested, affected units were cleaned, room ventilation was measured, and specimens were sent for whole-genome sequencing. A case-control study was done to compare clinical interactions, personal protective equipment use, and breakroom and workroom practices in SARS-CoV-2-positive versus negative staff. MEASUREMENTS Description of the cluster, mitigation activities, and risk factor analysis.

RESULTS:

Fourteen patients and 38 staff members were included in the cluster per whole-genome sequencing and epidemiologic associations. The index case was a symptomatic patient in whom isolation was discontinued after 2 negative results on nasopharyngeal polymerase chain reaction testing. The patient subsequently infected multiple roommates and staff, who then infected others. Seven of 52 (13%) secondary infections were detected only on second or subsequent tests. Eight of 9 (89%) patients who shared rooms with potentially contagious patients became infected. Potential contributing factors included high viral loads, nebulization, and positive pressure in the index patient's room. Risk factors for transmission to staff included presence during nebulization, caring for patients with dyspnea or cough, lack of eye protection, at least 15 minutes of exposure to case patients, and interactions with SARS-CoV-2-positive staff in clinical areas. Whole-genome sequencing confirmed that 2 staff members were infected despite wearing surgical masks and eye protection.

LIMITATION:

Findings may not be generalizable.

CONCLUSION:

SARS-CoV-2 clusters can occur in hospitals despite robust infection control policies. Insights from this cluster may inform additional measures to protect patients and staff. PRIMARY FUNDING SOURCE None.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Cross Infection / Infection Control / Infectious Disease Transmission, Patient-to-Professional / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Female / Humans / Male Country/Region as subject: North America Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Cross Infection / Infection Control / Infectious Disease Transmission, Patient-to-Professional / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Female / Humans / Male Country/Region as subject: North America Language: English Journal: Ann Intern Med Year: 2021 Document Type: Article